• 2-Deoxy-D-glucose: Applied Glycolysis Inhibition in Cancer R

  2026-04-21

  2-Deoxy-D-glucose (2-DG) from APExBIO enables researchers to precisely disrupt glycolytic metabolism in cancer and virology models, with distinct advantages for reproducibility and sensitivity. This article delivers actionable workflows, troubleshooting guidance, and insight into exploiting metabolic stress for translational assays.

• METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC

  2026-04-21

  Wang et al. (2024) identify the METTL16-SENP3-LTF signaling axis as a critical regulator of ferroptosis resistance and tumorigenesis in hepatocellular carcinoma (HCC). Their mechanistic insights reveal a potential therapeutic target for overcoming ferroptosis resistance—an emerging vulnerability in HCC treatment.

• DAPI Solution (1 mg/mL): Optimizing Nuclear Visualization in

  2026-04-20

  APExBIO’s DAPI Solution (1 mg/mL) enables high-contrast nuclear visualization, crucial for apoptosis detection in both fixed and compromised cells. This article details experimental workflows, troubleshooting strategies, and leverages evidence from recent cancer-microbiome research to guide optimal use in advanced cell viability and DNA staining assays.

• Staurosporine in Quantitative Apoptosis Profiling: From Frac

  2026-04-20

  Discover how Staurosporine, a broad-spectrum serine/threonine protein kinase inhibitor, transforms quantitative apoptosis profiling and angiogenesis research. This article uniquely integrates high-throughput microscopy protocols and advanced assay design strategies, offering insights beyond standard usage.

• PKM2 Enhances TGF-β1 Signaling and Drives Pulmonary Fibrosis

  2026-04-19

  This study uncovers a new mechanism in idiopathic pulmonary fibrosis, showing that PKM2 stabilizes TGF-β1 receptor I via direct interaction with Smad7, amplifying profibrotic signaling. These insights refine our understanding of fibrotic disease pathogenesis and highlight potential molecular targets for future intervention.

• Ibotenic Acid: NMDA Receptor Agonist for Neurodegeneration M

  2026-04-18

  Ibotenic acid, a potent NMDA receptor agonist, enables precise glutamatergic signaling modulation in neuroscience research. Its high solubility and reproducibility make it indispensable for developing robust animal models of neurodegenerative disorders and dissecting pain circuits. Discover advanced workflow optimizations, troubleshooting strategies, and implications from recent brain-to-spinal circuit studies.

• DRB and CDK Inhibition: Unleashing Cell Fate Control for Tra

  2026-04-17

  This thought-leadership article dissects the mechanistic underpinnings and translational potential of 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB), a potent inhibitor of cyclin-dependent kinases (CDKs) and RNA polymerase II elongation. By synthesizing new evidence from phase separation biology, stem cell engineering, and antiviral research, we provide actionable strategic guidance for translational scientists. This article stands apart by connecting DRB’s molecular pharmacology to the emerging concept of biomolecular condensates and cell fate control, going far beyond standard product pages. Practical protocol parameters and a candid assessment of cross-domain potential are included.

• Nose-to-Brain Rotigotine Nanoparticles for Parkinson's Model

  2026-04-16

  This study demonstrates the development and evaluation of chitosan-based nanoparticles for nose-to-brain delivery of rotigotine in cellular and animal models of Parkinson's disease. The approach significantly improves drug bioavailability, enhances neuroprotection, and modulates key PD biomarkers, highlighting its translational potential for targeted antiparkinsonian therapy.

• Calpain Inhibitor I, ALLN: Protocols and QC for Research Use

  2026-04-15

  Calpain Inhibitor I (ALLN) (SKU A2602) enables precise inhibition of calpain and cathepsin activity, supporting apoptosis and inflammation research assays where selective protease inhibition is critical. It is not suitable for diagnostic or therapeutic applications and should only be used in research workflows where compound solubility, cytotoxicity, and storage conditions can be tightly controlled.

• 6-Thioguanine Suppresses EV71 Replication via BIRC3-Autophag

  2026-04-14

  This study reveals that 6-thioguanine (6-TG), an established antineoplastic agent, potently inhibits Enterovirus 71 (EV71) replication by targeting the BIRC3-mediated autophagy pathway. These findings highlight a previously uncharacterized antiviral mechanism and suggest new possibilities for repurposing 6-TG in hand, foot, and mouth disease (HFMD) research.

• Dual-Action Kinase Inhibitors Accelerate p38α MAPK Dephospho

  2026-04-13

  This study reveals that certain kinase inhibitors not only block p38α MAPK activity but also enhance its dephosphorylation by phosphatases. These findings illuminate a conformational mechanism underlying targeted inflammatory pathway modulation, with direct implications for designing next-generation inhibitors in cytokine-related research.

• CD40 and STING Competition Modulates B Cell Activation in ES

  2026-04-12

  This study illuminates how competitive binding of CD40 and STING to TRAF2 orchestrates IRF4-mediated B cell activation via the non-canonical NF-κB pathway in esophageal squamous cell carcinoma (ESCC). The findings enhance mechanistic understanding of tertiary lymphoid structures (TLS) and their prognostic relevance, offering new angles for biomarker and therapeutic strategy development.

• Sorafenib (BAY-43-9006) in Cancer Biology: Protocols & Insig

  2026-04-12

  Sorafenib (BAY-43-9006) is a proven multikinase inhibitor essential for dissecting angiogenesis and tumor proliferation pathways. This guide delivers practical workflows, troubleshooting strategies, and highlights from recent research, empowering scientists to harness Sorafenib for advanced cancer biology applications.

• Amphotericin B: Polyene Antifungal Workflows & Assay Mastery

  2026-04-11

  Harness the full research potential of Amphotericin B, a gold-standard polyene antifungal antibiotic, by integrating evidence-based protocols, troubleshooting insights, and innovative use-cases. Discover how real-world experimental refinements and comparative benchmarks fuel data integrity and reproducibility in fungal infection research.

• Lypressin Acetate: Experimental Workflows for Vasopressor Re

  2026-04-11

  Lypressin acetate enables precision in vasopressor activity assays, GPCR signaling studies, and emerging antiviral research. This article delivers actionable workflows, troubleshooting strategies, and cross-domain insights to help researchers harness its full potential with reproducibility and confidence.

329 records 6/22 page Previous Next First page 上5页 678910 下5页 Last page